UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 65 filers reported holding UROGEN PHARMA LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $42,000 | -68.4% | 2,369 | -40.6% | 0.02% | -60.9% |
| Q4 2019 | $133,000 | -62.7% | 3,987 | -73.4% | 0.05% | -65.7% |
| Q3 2019 | $357,000 | -33.8% | 15,000 | 0.0% | 0.13% | -34.0% |
| Q2 2019 | $539,000 | -2.7% | 15,000 | 0.0% | 0.20% | -15.1% |
| Q1 2019 | $554,000 | -14.2% | 15,000 | 0.0% | 0.24% | -25.5% |
| Q4 2018 | $646,000 | -8.8% | 15,000 | 0.0% | 0.32% | +10.3% |
| Q3 2018 | $708,000 | +42.2% | 15,000 | +50.0% | 0.29% | +24.9% |
| Q2 2018 | $498,000 | +122.3% | 10,000 | +122.2% | 0.23% | +113.8% |
| Q1 2018 | $224,000 | – | 4,500 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Horton Capital Management, LLC | 684,749 | $11,517,000 | 23.27% |
| GREAT POINT PARTNERS LLC | 750,000 | $12,615,000 | 2.94% |
| HealthInvest Partners AB | 75,000 | $1,262,000 | 1.89% |
| Wildcat Capital Management, LLC | 533,139 | $8,967,000 | 1.16% |
| Annandale Capital, LLC | 86,254 | $1,451,000 | 0.87% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $49,698,000 | 0.73% |
| ZEKE CAPITAL ADVISORS, LLC | 723,677 | $12,172,000 | 0.70% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $426,000 | 0.34% |
| RTW INVESTMENTS, LP | 857,464 | $14,423,000 | 0.22% |
| SHIKIAR ASSET MANAGEMENT INC | 33,350 | $561,000 | 0.16% |